Skip to content

Complex Non- Sterile Compounding: Proposed USP <795> and Pharmaceutical Calculations: 2020-2021 Update

This activity is designed to meet the educational needs of compounding pharmacists.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Describe the changes between current and proposed USP <795>.
  • Determine the assigned beyond use date for a non-sterile preparation based on its dosage form and water activity.
  • Develop a training program for Non-Sterile Compounding personnel.
  • Determine appropriate components that are used in non-sterile compounding.

Presenter

Omar Allibhai, PharmD, RPh, FACA:
Omar Allibhai, PharmD, RPh, FACA is a registered pharmacist at Johnson Compounding & Wellness. He is the first pharmacist to complete a two year post-doctoral fellowship in pharmacy compounding in the nation. Omar works in different aspects of the pharmacy including non-sterile compounding, formulation development, training new employees, and developing quality assurance programs. He obtained his Doctor of Pharmacy degree and a certificate in radio-pharmacy from MCPHS University. He is a member of the Massachusetts Independent Pharmacists Association, Massachusetts Pharmacist Association, International Academy of Compounding Pharmacists, American College of Apothecaries and the Johnson Compounding and Wellness’s Quality Assurance team.

Registration Fee: Free to MCPHS Alumni and full-time employees; $12.00 for all other professionals.

Register


ACPE logo

Release Date: November 11, 2020
Expiration Date: November 8, 2021
Contact Hours: 1.25
Universal Activity Number: 0026-0000-20-232-H03-P

Accreditation

MCPHS University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1.25 contact hours (0.125 CEUs).

Requirements for Credit

In order to receive credit, the participant must review the entire presentation and complete the post-test and evaluation form. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

MCPHS University adheres to the ACPE Standards regarding commercial support of continuing pharmacy education. It is the policy of MCPHS University that the speakers and planning committee disclose real or apparent conflicts of interest relating to the topics of the educational activity, that relevant conflicts of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drugs or devices during their presentation.

No funding from industry provided for this event. No exhibitors will be present.
Omar Allibhai, PharmD, RPh, FACA has no relevant financial relationships to disclose.
All CE staff members have no relevant financial relationships to disclose.